Results 141 to 150 of about 121,048 (155)

Assessing symptomatic vulvar, vaginal, and lower urinary tract atrophy

Climacteric, 2019
Santiago Palacios
exaly  

Incidence of genitourinary conditions in women with a diagnosis of vulvar/vaginal atrophy

Current Medical Research and Opinion, 2014
Rossella E Nappi, Liisa Palmer
exaly  

Vulvar and vaginal atrophy as viewed by the Spanish REVIVE participants: symptoms, management and treatment perceptions

Climacteric, 2017
Placido Llaneza Coto, Santiago Palacios
exaly  

Systematic indirect comparison of ospemifene versus local estrogens for vulvar and vaginal atrophy

Climacteric, 2017
Marco Anelli, Santiago Palacios, A O Mueck   +2 more
exaly  

Ospemifene for the treatment of postmenopausal vulvar and vaginal atrophy: recommendations for clinical use

Expert Opinion on Pharmacotherapy, 2015
JoAnn Pinkerton, Risa Kagan
exaly  

Female sexual function improved with ospemifene in postmenopausal women with vulvar and vaginal atrophy: results of a randomized, placebo-controlled trial

Climacteric, 2015
R C Rosen, S A Kingsberg, G Constantine
exaly  

Vulvar and Vaginal Atrophy in Postmenopausal Women: Findings from the REVIVE (REal Women's VIews of Treatment Options for Menopausal Vaginal ChangEs) Survey

Journal of Sexual Medicine, 2013
Sheryl A Kingsberg, Michael L Krychman
exaly  

The Women's EMPOWER Survey: Identifying Women's Perceptions on Vulvar and Vaginal Atrophy and Its Treatment

Journal of Sexual Medicine, 2017
Sheryl A Kingsberg, Brian Bernick, Michael Krychman   +2 more
exaly  

The Women's EMPOWER Survey: Women's Knowledge and Awareness of Treatment Options for Vulvar and Vaginal Atrophy Remains Inadequate

Journal of Sexual Medicine, 2017
Sheryl A Kingsberg, Brian Bernick, Michael Krychman   +2 more
exaly  

TX-004HR clinically improves symptoms of vulvar and vaginal atrophy in postmenopausal women

Climacteric, 2019
J A Simon, D F Archer
exaly